Jinwon Life Sciences Reports Operating Loss of 8.5 Billion KRW Last Year
[Asia Economy Reporter Park Jihwan] GeneOne Life Science announced on the 21st that its operating loss based on the consolidated financial statements for last year was 8.5 billion KRW, a 24.5% decrease in the deficit compared to the previous year.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Sales amounted to 41.2 billion KRW, an increase of 20.3% compared to the previous year. The net loss for the period was 7.5 billion KRW, a 36.7% reduction in the loss compared to the previous year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
